Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589149 | SCV000699432 | benign | not provided | 2016-10-24 | criteria provided, single submitter | clinical testing | Variant summary: The CHD7 c.1326C>A (p.Ala442Ala) variant causes a synonymous change involving a conserved nucleotide with 5/5 splice prediction tools predict no significant impact on normal splicing or alterations to ESE binding, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 20/120690 (1/60350), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic CHD7 variant of 1/769230. Therefore, suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic. Taking all available lines of evidence into consideration, the variant of interest has been classified as Benign. |
Invitae | RCV001084059 | SCV001009704 | likely benign | CHARGE association | 2022-10-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589149 | SCV001759327 | likely benign | not provided | 2021-09-08 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821714 | SCV002066615 | uncertain significance | not specified | 2017-08-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384287 | SCV002691586 | likely benign | Inborn genetic diseases | 2018-01-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |